Enhancing the Patient Journey to Clinical Trial Enrolment With Navigation to Optimize Accrual (NCT06905002)
Enhancing the Patient Journey to Clinical Trial Enrolment With Navigation to Optimize Accrual: A Pilot Study for a Prospective, Pragmatic Multi-centre, Stepped Wedge, Cluster Randomized Controlled Trial
๐ฉบ Plain-English Summary (8th-Grade Level)
Less than 5% of patient enter clinical trials, despite the fact that many patients facing cancer are recommended to seek out clinical trials. One challenge of finding a clinical trial, is the lack of clinical trials at the patient's home cancer centre. The Clinical Trials Navigator (CTN) program was established to help patients, their families and heath care providers navigate the clinical trials systems across Canada in order to identify meaningful clinical trials for patients and help them enter those trials. The CTN program was piloted in Windsor, Ontario and increased clinical trials accrual for this population by 8%. This study plans to roll out to twenty centres across Canada, mimicing the process. This implementation of the CTN program will be tested by adding centres in a sequential fashion until all centres are added over the 12 month period. The objectives are improved patient enrollment which will be measured by embedded CTNs in each cancer centre, and reporting to the central site. Pre- and post-implementation structured interviews with administrators, physicians, patients and allied health care professionals will be used to assess uptake of the CTN program in each centre and reveal potential barriers to successful implementation of a nation-wide CTN program. The ability of the current CTN program to upscale to twenty centres will be measured by turn-around times of patient reports and through the structured interviews.
Who can join: Review the eligibility criteria below.
Location: Thunder Bay Regional Health Sciences Centre โ Thunder Bay, Ontario
๐งช Interventions in This Study
- Educational program (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (2 Sites)
- Thunder Bay Regional Health Sciences Centre โ Thunder Bay, Ontario
- Windsor Regional Hospital โ Windsor, Ontario
๐ Contact the Study Coordinator
Phone: (519) 253-5253
Email: caroline.hamm@wrh.on.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cancer
- Ovarian Tissue Cryopreservation in Children โ Rochester, Minnesota
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study โ Aurora, Colorado
- Ex Onc SLED: A Study Utilizing A Weighted Sled for Horizontal Resistance Training โ Pittsburgh, Pennsylvania
- An Internet-based Program to Help Cancer Survivors Manage Pain โ Fort Smith, Arkansas
- Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors โ Toronto, Ontario
- Researching the Effect of Aerobic Exercise on Cancer โ Los Angeles, California
Explore by condition: All Cancer clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.